Results 131 to 140 of about 1,087,264 (262)

Cascaded Broadband Low-Frequency Microwave Absorption Covering P- to C-Band in Ultra-Thin Metamaterials via Synergistic Local‑Field and Loss‑Field Enhancement. [PDF]

Nanomicro Lett
Yang Q, Hou H, Lu Y, Guo Z, Sun J, Zhang P, Yang T, Meng F.   +7 more
europepmc   +1 more source

Thin-film InGaAs metamorphic buffer for telecom C-band InAs quantum dots and optical resonators on GaAs platform. [PDF]

Nanophotonics, 2022
Sittig R, Nawrath C, Kolatschek S, Bauer S, Schaber R, Huang J, Vijayan P, Pruy P, Portalupi SL, Jetter M, Michler P.   +10 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Developing and examining a compact dual band circularly polarized ultra-wideband antenna covering C-band and X-band applications. [PDF]

Sci Rep
Kolusu D, Nanda S.
europepmc   +1 more source

Wave discrimination at C-band frequencies in microstrip structures inspired by electromagnetically induced transparency. [PDF]

Sci Rep, 2021
Jabbar A, Ramzan R, Siddiqui O, Amin M, Tahir FA.   +4 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Inhalt des C. Bandes [PDF]

Zeitschrift der Savigny-Stiftung für Rechtsgeschichte: Germanistische Abteilung, 1983
  +4 more sources

Compact Frequency-Agile and Mode-Reconfigurable Antenna for C-Band, Sub-6-GHz-5G, and ISM Applications. [PDF]

Micromachines (Basel)
Ali EM, Awan WA, Abbas A, Abbas SM, Mohamed HG.   +4 more
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

A compact C-band FLASH electron linear accelerator prototype for the VHEE SAFEST project. [PDF]

Front Oncol
Giuliano L, Alesini D, Cardelli F, Carillo M, Chiadroni E, Coppola M, Cuttone G, Curcio A, De Gregorio A, Raddo RD, Faillace L, Farina S, Ficcadenti L, Francescone D, Franciosini G, Franzini G, Gallo A, Magi M, Mauro GS, Mostacci A, Palumbo L, Patera V, Perondi F, Petrarca M, Pioli S, Remetti R, Sarti A, Schiavi A, Spataro B, Torrisi G, Vannozzi A, Migliorati M.   +31 more
europepmc   +1 more source